Clinical Trial Update: Cord Blood Transplantation for Patients With Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cord blood transplantation for cancer in patients with hematological disease has been terminated. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Disease

Snippet

Sponsor: University of Chicago | Conditions: Hematological Disease | Phase 2 | Status: TERMINATED | Results posted: 2015-04-30